NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 153 filers reported holding NEWLINK GENETICS CORP in Q4 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $213,000 | -60.1% | 12,400 | -15.1% | 0.00% | -50.0% |
| Q4 2015 | $534,000 | +3.5% | 14,600 | +1.4% | 0.01% | 0.0% |
| Q3 2015 | $516,000 | -14.3% | 14,400 | +5.9% | 0.01% | -14.3% |
| Q2 2015 | $602,000 | -16.3% | 13,600 | +3.4% | 0.01% | -22.2% |
| Q1 2015 | $719,000 | +22.9% | 13,150 | -12.3% | 0.01% | +28.6% |
| Q4 2014 | $585,000 | +67.6% | 15,000 | -8.0% | 0.01% | +40.0% |
| Q3 2014 | $349,000 | -17.9% | 16,300 | +1.9% | 0.01% | -16.7% |
| Q2 2014 | $425,000 | -2.7% | 16,000 | +3.9% | 0.01% | -14.3% |
| Q1 2014 | $437,000 | +31.2% | 15,400 | +5.5% | 0.01% | +40.0% |
| Q4 2013 | $333,000 | +23.8% | 14,600 | +2.1% | 0.01% | 0.0% |
| Q3 2013 | $269,000 | +10.7% | 14,300 | +11.7% | 0.01% | 0.0% |
| Q2 2013 | $243,000 | – | 12,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FT Options LLC | 21,900 | $1,292,000 | 1.11% |
| TIVERTON ASSET MANAGEMENT LLC | 288,807 | $18,215,000 | 0.77% |
| Knoll Capital Management, LLC | 102,437 | $1,153,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 460,146 | $5,181,000 | 0.36% |
| WALL STREET ASSOCIATES | 79,000 | $890,000 | 0.36% |
| Endurant Capital Management LP | 62,491 | $704,000 | 0.24% |
| FT Options LLC | 21,903 | $247,000 | 0.21% |
| Virtus ETF Advisers LLC | 24,463 | $275,000 | 0.20% |
| Orbimed Advisors | 1,581,506 | $17,808,000 | 0.19% |
| HAP Trading, LLC | 227,728 | $2,564,000 | 0.15% |